Contact this trialFirst, we need to learn more about you.
NMDA Receptor Antagonist
Oral Ketamine for Anxiety in Pancreatic Cancer Patients
Recruiting0 awardsPhase < 1
Los Angeles, California
This trial is testing whether ketamine or a placebo can help treat anxiety in cancer patients who are receiving or have recently received cancer targeted therapy. The study will look at feasibility, safety, and tolerability, and also at the effect of ketamine/placebo on things like depression, anxiety, pain, fatigue, and sleep disturbance.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service